End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 CNY | 0.00% | -6.80% | +3.23% |
Apr. 15 | Kangmei Pharmaceutical Returns to Profit in 2023; Shares Decline 4% | MT |
Apr. 12 | Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 4.18B 578M | Sales 2023 | 4.87B 673M | Capitalization | 25.79B 3.56B |
---|---|---|---|---|---|
Net income 2022 | -2.69B -372M | Net income 2023 | 103M 14.23M | EV / Sales 2022 | 7 x |
Net cash position 2022 | 1.24B 172M | Net cash position 2023 | 802M 111M | EV / Sales 2023 | 5.13 x |
P/E ratio 2022 |
-11.6
x | P/E ratio 2023 |
186
x | Employees | 4,409 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.44% |
1 week | -6.80% | ||
Current month | -11.52% | ||
1 month | -2.54% | ||
3 months | +6.08% | ||
Current year | +3.23% |
Managers | Title | Age | Since |
---|---|---|---|
Guo Wei Liu
CEO | Chief Executive Officer | 51 | 20-10-09 |
Gui Bo Gong
DFI | Director of Finance/CFO | 50 | 20-10-09 |
Min Li
IRC | Investor Relations Contact | 35 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xiao Ping Lai
BRD | Director/Board Member | 63 | 20-10-29 |
Yan Zhu Gao
CHM | Chairman | 59 | 20-10-29 |
Qi Mi
BRD | Director/Board Member | 62 | 22-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2,808 M€ | +3.50% | - | |
0.00% | 441 M€ | +1.32% | - | |
0.00% | 149 M€ | -1.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1.92 | 0.00% | 78,029,760 |
24-04-17 | 1.92 | +1.59% | 117,890,400 |
24-04-16 | 1.89 | -5.03% | 194,321,200 |
24-04-15 | 1.99 | -4.78% | 194,805,200 |
24-04-12 | 2.09 | +1.46% | 122,637,600 |
End-of-day quote Shanghai S.E., April 17, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.23% | 3.68B | |
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- 600518 Stock